Fmoc-Sec(Mob)-Oh 100 Mg | 8.52346.8100 | Merck

Merck Chemicals Dealer | eqipped

Fmoc-Sec(Mob)-Oh 100 Mg | 8.52346.8100 | Merck

Fmoc-Sec(Mob)-Oh, High Purity, Ideal for Lab Research.

Category Brand:

22,990.00

Description

Specifications Table

Product Name – Fmoc-Sec(Mob)-Oh 100 Mg
Quantity/Pack Size – 100 Mg
Form – Powder
Grade – Lab-Grade
Application – Peptide Synthesis

Product Overview

Fmoc-Sec(Mob)-Oh 100 Mg is a high-quality reagent designed for peptide synthesis, ensuring optimal results in laboratory settings. This compound is synthesized to meet strict purity standards, making it ideal for researchers and educators who require reliable performance in their experiments. The Fmoc (9-fluorenylmethyloxycarbonyl) protection group ensures compatibility with standard solid-phase peptide synthesis protocols, while the Sec(Mob) modification provides enhanced stability and reactivity. This reagent is particularly valued for its consistency and ease of handling, making it a preferred choice for academic and industrial laboratories alike.

FAQs

1. What is the primary use of Fmoc-Sec(Mob)-Oh 100 Mg?

It is primarily used in peptide synthesis for incorporating selenocysteine residues into peptides.

2. Is this reagent compatible with standard Fmoc-based peptide synthesis protocols?

Yes, it is fully compatible with Fmoc-based solid-phase peptide synthesis methods.

3. What storage conditions are recommended for this product?

Store at -20°C in a dry, dark place to maintain stability and purity.

4. Can this reagent be used in automated peptide synthesizers?

Yes, it is suitable for use in automated peptide synthesis equipment.

5. Are there alternatives to Fmoc-Sec(Mob)-Oh for peptide synthesis?

Other selenocysteine derivatives like Fmoc-Sec(Trt)-OH may be considered, but this reagent offers specific advantages in stability and reactivity.

— This format ensures SEO optimization, clarity, and relevance for Indian B2C buyers in the lab supplies market.

Do You Want Best Price?

Take 3 minutes to share your Details.